Cytosorbents Corp Common Stock Shares Outstanding

• Cytosorbents Corp showed an increase of +14.5% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Cytosorbents Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), Cytosorbents Corp's Common Stock Shares Outstanding has declined by 48.9%.
• Historical annual values: Fiscal year 2025: 62.80 million shares | Fiscal year 2024: 54.83 million shares | Fiscal year 2023: 54.24 million shares | Fiscal year 2022: 43.64 million shares | Fiscal year 2021: 43.64 million shares | Fiscal year 2020: 43.22 million shares | Fiscal year 2019: 32.62 million shares | Fiscal year 2018: 31.77 million shares | Fiscal year 2017: 28.97 million shares | Fiscal year 2016: 25.48 million shares | Fiscal year 2015: 25.40 million shares | Fiscal year 2014: 23.30 million shares | Fiscal year 2013: 10.05 million shares | Fiscal year 2012: 214.97 million shares | Fiscal year 2011: 177.63 million shares | Fiscal year 2010: 122.84 million shares.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026